Surgery Capex To Revenue vs Days Payables Outstanding Analysis

SGRY Stock

USD 25.05 0.00 0.00%

Surgery Partners financial indicator trend analysis is much more than just breaking down Surgery Partners prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Surgery Partners is a good investment. Please check the relationship between Surgery Partners Capex To Revenue and its Days Payables Outstanding accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgery Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.

Capex To Revenue vs Days Payables Outstanding

Capex To Revenue vs Days Payables Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Surgery Partners Capex To Revenue account and Days Payables Outstanding. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Surgery Partners' Capex To Revenue and Days Payables Outstanding is -0.49. Overlapping area represents the amount of variation of Capex To Revenue that can explain the historical movement of Days Payables Outstanding in the same time period over historical financial statements of Surgery Partners, assuming nothing else is changed. The correlation between historical values of Surgery Partners' Capex To Revenue and Days Payables Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Revenue of Surgery Partners are associated (or correlated) with its Days Payables Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Days Payables Outstanding has no effect on the direction of Capex To Revenue i.e., Surgery Partners' Capex To Revenue and Days Payables Outstanding go up and down completely randomly.

Correlation Coefficient

-0.49

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Days Payables Outstanding

Most indicators from Surgery Partners' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Surgery Partners current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgery Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.At this time, Surgery Partners' Tax Provision is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.07 in 2025, whereas Selling General Administrative is likely to drop slightly above 80.8 M in 2025.

	2022	2023	2024	2025 (projected)
Interest Expense	234.9M	193M	222.0M	148.4M
Depreciation And Amortization	149.6M	118.1M	135.8M	80.6M

Interest Expense Depreciation And Amortization

Surgery Partners fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets
Common Stock Shares Outstanding		0.73	0.66	0.42	0.68	0.92	-0.09	0.88	0.67	-0.77	0.92	0.53	0.73	0.88	0.07	0.67	0.53	0.76	0.71	0.63	0.76	0.34	0.93	0.49	0.92	0.72
Total Assets	0.73		0.98	0.81	0.98	0.79	0.28	0.9	0.98	-0.74	0.89	0.85	1.0	0.8	0.3	0.98	0.85	0.99	1.0	0.96	0.99	0.5	0.76	0.88	0.86	0.98
Short Long Term Debt Total	0.66	0.98		0.87	0.99	0.7	0.43	0.87	1.0	-0.73	0.85	0.88	0.98	0.71	0.36	1.0	0.88	0.97	0.98	0.99	0.96	0.44	0.67	0.92	0.81	0.97
Other Current Liab	0.42	0.81	0.87		0.82	0.46	0.41	0.66	0.87	-0.43	0.65	0.68	0.82	0.47	0.17	0.87	0.68	0.78	0.84	0.89	0.76	0.44	0.39	0.87	0.57	0.76
Total Current Liabilities	0.68	0.98	0.99	0.82		0.73	0.43	0.89	0.98	-0.78	0.86	0.9	0.98	0.73	0.37	0.98	0.9	0.98	0.97	0.96	0.97	0.4	0.72	0.89	0.84	0.98
Total Stockholder Equity	0.92	0.79	0.7	0.46	0.73		-0.14	0.92	0.7	-0.76	0.95	0.61	0.79	0.97	0.13	0.69	0.61	0.8	0.77	0.67	0.81	0.45	0.98	0.59	0.96	0.79
Other Liab	-0.09	0.28	0.43	0.41	0.43	-0.14		0.13	0.4	-0.26	0.07	0.63	0.27	-0.13	0.65	0.43	0.63	0.3	0.29	0.43	0.27	-0.05	-0.06	0.47	0.05	0.39
Property Plant And Equipment Net	0.88	0.9	0.87	0.66	0.89	0.92	0.13		0.88	-0.86	0.99	0.75	0.9	0.9	0.23	0.87	0.75	0.9	0.88	0.84	0.9	0.36	0.92	0.76	0.99	0.89
Net Debt	0.67	0.98	1.0	0.87	0.98	0.7	0.4	0.88		-0.74	0.85	0.85	0.98	0.71	0.33	1.0	0.85	0.97	0.98	0.98	0.96	0.42	0.67	0.9	0.82	0.96
Retained Earnings	-0.77	-0.74	-0.73	-0.43	-0.78	-0.76	-0.26	-0.86	-0.74		-0.82	-0.68	-0.73	-0.79	-0.3	-0.72	-0.68	-0.79	-0.69	-0.65	-0.78	0.03	-0.85	-0.6	-0.87	-0.79
Accounts Payable	0.92	0.89	0.85	0.65	0.86	0.95	0.07	0.99	0.85	-0.82		0.72	0.89	0.93	0.18	0.85	0.72	0.9	0.88	0.83	0.9	0.43	0.94	0.72	0.99	0.88
Cash	0.53	0.85	0.88	0.68	0.9	0.61	0.63	0.75	0.85	-0.68	0.72		0.84	0.63	0.61	0.87	1.0	0.84	0.84	0.87	0.83	0.38	0.62	0.89	0.71	0.91
Non Current Assets Total	0.73	1.0	0.98	0.82	0.98	0.79	0.27	0.9	0.98	-0.73	0.89	0.84		0.8	0.28	0.97	0.84	0.99	1.0	0.96	0.99	0.51	0.76	0.88	0.86	0.98
Non Currrent Assets Other	0.88	0.8	0.71	0.47	0.73	0.97	-0.13	0.9	0.71	-0.79	0.93	0.63	0.8		0.08	0.71	0.63	0.81	0.78	0.69	0.83	0.44	0.96	0.65	0.93	0.8
Other Assets	0.07	0.3	0.36	0.17	0.37	0.13	0.65	0.23	0.33	-0.3	0.18	0.61	0.28	0.08		0.35	0.61	0.3	0.29	0.34	0.27	0.01	0.18	0.42	0.22	0.4
Long Term Debt	0.67	0.98	1.0	0.87	0.98	0.69	0.43	0.87	1.0	-0.72	0.85	0.87	0.97	0.71	0.35		0.87	0.96	0.98	0.99	0.96	0.46	0.67	0.91	0.81	0.96
Cash And Short Term Investments	0.53	0.85	0.88	0.68	0.9	0.61	0.63	0.75	0.85	-0.68	0.72	1.0	0.84	0.63	0.61	0.87		0.84	0.84	0.87	0.83	0.38	0.62	0.89	0.71	0.91
Net Receivables	0.76	0.99	0.97	0.78	0.98	0.8	0.3	0.9	0.97	-0.79	0.9	0.84	0.99	0.81	0.3	0.96	0.84		0.98	0.94	1.0	0.46	0.79	0.84	0.87	0.99
Good Will	0.71	1.0	0.98	0.84	0.97	0.77	0.29	0.88	0.98	-0.69	0.88	0.84	1.0	0.78	0.29	0.98	0.84	0.98		0.97	0.98	0.54	0.73	0.89	0.84	0.97
Non Current Liabilities Total	0.63	0.96	0.99	0.89	0.96	0.67	0.43	0.84	0.98	-0.65	0.83	0.87	0.96	0.69	0.34	0.99	0.87	0.94	0.97		0.94	0.55	0.63	0.93	0.77	0.95
Inventory	0.76	0.99	0.96	0.76	0.97	0.81	0.27	0.9	0.96	-0.78	0.9	0.83	0.99	0.83	0.27	0.96	0.83	1.0	0.98	0.94		0.49	0.8	0.84	0.88	0.99
Other Current Assets	0.34	0.5	0.44	0.44	0.4	0.45	-0.05	0.36	0.42	0.03	0.43	0.38	0.51	0.44	0.01	0.46	0.38	0.46	0.54	0.55	0.49		0.32	0.45	0.34	0.45
Other Stockholder Equity	0.93	0.76	0.67	0.39	0.72	0.98	-0.06	0.92	0.67	-0.85	0.94	0.62	0.76	0.96	0.18	0.67	0.62	0.79	0.73	0.63	0.8	0.32		0.55	0.96	0.78
Total Liab	0.49	0.88	0.92	0.87	0.89	0.59	0.47	0.76	0.9	-0.6	0.72	0.89	0.88	0.65	0.42	0.91	0.89	0.84	0.89	0.93	0.84	0.45	0.55		0.68	0.88
Property Plant And Equipment Gross	0.92	0.86	0.81	0.57	0.84	0.96	0.05	0.99	0.82	-0.87	0.99	0.71	0.86	0.93	0.22	0.81	0.71	0.87	0.84	0.77	0.88	0.34	0.96	0.68		0.86
Total Current Assets	0.72	0.98	0.97	0.76	0.98	0.79	0.39	0.89	0.96	-0.79	0.88	0.91	0.98	0.8	0.4	0.96	0.91	0.99	0.97	0.95	0.99	0.45	0.78	0.88	0.86

Click cells to compare fundamentals

Surgery Partners Account Relationship Matchups

Surgery Partners fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	48.8M	72.4M	92.0M	125.6M	144.5M	151.7M
Total Assets	5.4B	6.1B	6.7B	6.9B	7.9B	4.6B
Short Long Term Debt Total	3.2B	3.3B	2.9B	3.1B	3.5B	2.5B
Other Current Liab	353M	247.0M	242.5M	240.3M	276.3M	253.3M
Total Current Liabilities	556.8M	536.8M	493.4M	523M	601.5M	371.2M
Total Stockholder Equity	115.6M	1.1B	2.0B	2.0B	2.3B	2.4B
Other Liab	62.9M	440.6M	402.6M	35M	40.3M	38.2M
Property Plant And Equipment Net	854.7M	953.8M	1.2B	1.2B	1.4B	1.5B
Net Debt	2.9B	2.9B	2.6B	2.9B	3.3B	2.3B
Retained Earnings	(431.8M)	(502.7M)	(557.3M)	(569.2M)	(512.3M)	(537.9M)
Accounts Payable	100.2M	124.9M	151.6M	171.8M	197.6M	207.4M
Cash	317.9M	389.9M	282.9M	195.9M	225.3M	185.4M
Non Current Assets Total	4.6B	5.2B	5.8B	6.0B	6.9B	4.0B
Non Currrent Assets Other	27M	59.1M	144.2M	103.3M	118.8M	124.7M
Other Assets	129.5M	554M	5.2B	122.3M	140.6M	133.6M
Long Term Debt	2.8B	2.9B	2.6B	2.7B	3.1B	2.2B
Cash And Short Term Investments	317.9M	389.9M	282.9M	195.9M	225.3M	185.4M
Net Receivables	382.2M	430.2M	456.3M	496.4M	570.9M	332.0M
Good Will	3.5B	3.9B	4.1B	4.3B	5.0B	3.1B
Liabilities And Stockholders Equity	5.4B	6.1B	6.7B	6.9B	7.9B	4.6B
Non Current Liabilities Total	3.2B	3.3B	2.9B	3.0B	3.4B	2.6B
Inventory	56.4M	61.1M	71.4M	75.2M	86.5M	48.1M
Other Current Assets	45M	64.9M	110.4M	127.5M	146.6M	86.4M
Other Stockholder Equity	607.9M	1.6B	2.5B	2.5B	2.9B	3.0B
Total Liab	5.4B	6.1B	6.7B	3.5B	4.0B	4.3B
Property Plant And Equipment Gross	854.7M	1.2B	1.5B	1.7B	1.9B	2.0B
Total Current Assets	801.5M	946.1M	921M	895M	1.0B	626.5M
Accumulated Other Comprehensive Income	(61M)	(31.5M)	76.2M	57.5M	66.1M	69.4M
Short Term Debt	103.6M	100.5M	99.3M	110.9M	127.5M	70.8M
Intangible Assets	46.9M	43.7M	42.3M	54.8M	63.0M	53.2M
Property Plant Equipment	821M	854.7M	953.8M	1.2B	1.3B	1.4B
Net Tangible Assets	(3.2B)	(2.4B)	1.1B	(1.6B)	(1.8B)	(1.9B)
Current Deferred Revenue	109.8M	64.4M	3.2M	108.5M	124.8M	131.0M
Long Term Investments	90.3M	88.7M	190.3M	184.1M	211.7M	222.3M
Short Long Term Debt	64.4M	60.4M	62.8M	73.3M	84.3M	55.9M
Warrants	1.1B	741.3M	330.2M	342M	393.3M	673.0M
Noncontrolling Interest In Consolidated Entity	686.6M	766.5M	880.6M	942.7M	1.1B	724.6M
Common Stock Total Equity	395.5M	435M	900K	1.3M	1.5M	1.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Surgery Capex To Revenue vs Days Payables Outstanding Analysis

Capex To Revenue vs Days Payables Outstanding

Capex To Revenue vs Days Payables Outstanding Correlation Analysis

Correlation Coefficient

Capex To Revenue

Days Payables Outstanding

Surgery Partners fundamental ratios Correlations

Surgery Partners Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Surgery Partners fundamental ratios Accounts

Also Currently Popular

Additional Tools for Surgery Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Good Will	+ 1.0	Total Assets
Net Debt	+ 1.0	Short Long Term Debt Total
Long Term Debt	+ 1.0	Short Long Term Debt Total
Long Term Debt	+ 1.0	Net Debt
Cash And Short Term Investments	+ 1.0	Cash

Property Plant And Equipment Gross	- 0.87	Retained Earnings
Retained Earnings	- 0.86	Property Plant And Equipment Net
Other Stockholder Equity	- 0.85	Retained Earnings
Accounts Payable	- 0.82	Retained Earnings
Total Current Assets	- 0.79	Retained Earnings
Net Receivables	- 0.79	Retained Earnings